Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease

Overview of attention for article published in Frontiers in Pediatrics, October 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 11 X posts from 8 X users, with an upper bound of 32,694 followers.

RT @IronBiologyBot: Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease…

Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease https://t.co/pAwF3vMUwR #IronBiology #BioIron #Iron

RT @ASPNeph: Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease https:…

RT @ASPNeph: Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease https:…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.